Literature DB >> 24139897

Rhythm outcome predictors after concomitant surgical ablation for atrial fibrillation: a 9-year, single-center experience.

Simon Pecha1, Timm Schäfer2, Irina Subbotina2, Teymour Ahmadzade2, Hermann Reichenspurner2, Florian Mathias Wagner2.   

Abstract

OBJECTIVES: Concomitant surgical ablation is a safe and feasible procedure, recommended by the guidelines for patients with atrial fibrillation (AF) undergoing cardiac surgery. We performed a single-center data analysis to identify the predictors of rhythm outcome in such patients.
METHODS: From January 2003 to January 2012, 503 patients with persistent (n = 296, 58.8%) or paroxysmal (n = 207, 41.2%) AF underwent concomitant surgical AF ablation. The lesions were limited to a pulmonary vein isolation (n = 76, 15.1%), a more complex left atrial lesion set (n = 353, 70.2%), or biatrial lesions (n = 74, 14.7%). Follow-up rhythm evaluations were based on either 24-hour Holter electrocardiograms or event recorder interrogation at 3, 6, and 12 months postoperatively. A sinus rhythm (SR) immediately postoperatively was defined as the first documented rhythm after weaning from extracorporeal circulation.
RESULTS: The mean patient age was 68.0 ± 9.5 years, and 336 (66.8%) were men. No major ablation-related complications occurred. After 1 year of follow-up, 59.9% of all patients were in SR, with significantly better results in patients with paroxysmal AF than in those with persistent AF (67.3% vs 54.8%, P = .0053). Additional statistically significant factors influencing SR after 1 year were left atrial diameter (P = .0019), AF duration (P = .018), and immediate postoperative SR (P < .001). Regarding only patients with persistent or longstanding-persistent AF, those with biatrial lesions had significantly greater rates of conversion to SR than those with solitary left atrial ablation (SR, 64.9% vs 51.4%; P = .044) after 12 months.
CONCLUSIONS: The statistically significant predictors for SR after 1 year were left atrial diameter, AF duration, preoperative paroxysmal AF, immediate postoperative SR, and biatrial ablation for persistent AF.
Copyright © 2014 The American Association for Thoracic Surgery. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 24139897     DOI: 10.1016/j.jtcvs.2013.08.074

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

1.  Surgical management of atrial fibrillation at the time of septal myectomy.

Authors:  Eduard Quintana; James L Cox
Journal:  Ann Cardiothorac Surg       Date:  2017-07

2.  A minimally invasive Cox maze IV procedure is as effective as sternotomy while decreasing major morbidity and hospital stay.

Authors:  Christopher P Lawrance; Matthew C Henn; Jacob R Miller; Laurie A Sinn; Richard B Schuessler; Hersh S Maniar; Ralph J Damiano
Journal:  J Thorac Cardiovasc Surg       Date:  2014-06-06       Impact factor: 5.209

3.  Effectiveness of Surgical Ablation in Patients With Atrial Fibrillation and Aortic Valve Disease.

Authors:  Matthew C Henn; Christopher P Lawrance; Laurie A Sinn; Jacob R Miller; Richard B Schuessler; Marc R Moon; Spencer J Melby; Hersh S Maniar; Ralph J Damiano
Journal:  Ann Thorac Surg       Date:  2015-07-22       Impact factor: 4.330

4.  Application of cryoablation for the treatment of atrial fibrillation in patients undergoing cardiac surgery: Our mid-term results.

Authors:  Ahmet Arnaz; A Ümit Güllü; Ahmet Akyol; Ertuğrul Zencirci; Şahin Şenay; Aleks Değirmencioğlu; Muharrem Koçyiğit; Cem Alhan
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2018-01-09       Impact factor: 0.332

5.  Temporal trends and predictors of surgical ablation for atrial fibrillation across a multistate healthcare system.

Authors:  Scott C Brancato; Mansen Wang; Kateri J Spinelli; Maheer Gandhavadi; Neil K Worrall; Eric J Lehr; Zach M DeBoard; Torin P Fitton; Alison Leiataua; Jonathan P Piccini; Ty J Gluckman
Journal:  Heart Rhythm O2       Date:  2021-12-24

6.  Concomitant surgical ablation for atrial fibrillation (AF) in patients with significant atrial dilation >55 mm. Worth the effort?

Authors:  Simon Pecha; Samer Hakmi; Irina Subbotina; Stephan Willems; Hermann Reichenspurner; Florian Mathias Wagner
Journal:  J Cardiothorac Surg       Date:  2015-11-14       Impact factor: 1.637

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.